Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new ...

Orthopedic non-invasive stem cell therapy regenerates damaged tissue rather than just improving symptoms. Autologous stem cell therapy uses cells from your own body, minimizing rejection risks.

Gene therapy provides more quality-adjusted life-years versus non-myeloablative haploidentical allogeneic stem cell transplantation in sickle cell disease, but at a much higher cost. The cost of gene ...